
FSSAI files cases against Nestle India over Biotin-deficient formula
The story in brief
FSSAI has filed three adjudication cases against Nestle India over three infant nutrition products after lab tests found a follow-up formula sub-standard for Biotin. Re-analysis confirmed non-compliance with 2020 regulations, leading to a 2% drop in Nestle India's shares on the BSE.